Aldimine

Aldimine: Chemical Identity, Biochemical Roles, and Status in Nutritional and Biomedical Research

Overview and Important Caveat

Aldimine is not a single botanical ingredient, isolated natural compound, or recognized supplement monograph. It is instead a class of chemical functional groups and compounds defined by a specific molecular structure: imines derived from aldehydes, i.e., compounds having the structure RCH=NR. As such, aldimines are intermediates or structural motifs found across an enormous range of biological, pharmaceutical, and industrial chemical contexts. Any representation of "aldimine" as a standalone dietary supplement ingredient — with its own traditional use history or clinical supplement evidence — is not supported by peer-reviewed literature, government health body reviews, pharmacopeial monographs, or any other authoritative scientific source. This article therefore presents what authoritative sources do document: the chemistry, endogenous biological roles, pharmacological research on synthetic aldimine-type compounds, and the context in which the term appears in biochemistry and nutritional science.

Chemical Identity and Nomenclature

An aldimine is any Schiff base of the general formula RCH=NH or RCH=NR′ formed by condensation of an aldehyde with ammonia or a primary amine. The term entered scientific usage circa 1899, derived etymologically from ald- (from "aldehyde") combined with imine.

In organic chemistry, a Schiff base (named after Hugo Schiff) is a compound with the general structure featuring a carbon–nitrogen double bond. They can be considered a sub-class of imines, being either secondary ketimines or secondary aldimines depending on their structure. The carbon–nitrogen double bond in Schiff bases formed as a result of the reaction of primary amines with aldehydes is called azomethine or aldimine, while the bond formed as a result of the reaction with a ketone is called imine or ketimine.

If one of the groups on the carbon is a hydrogen atom, the compound is called an aldimine; if both are non-hydrogen organic groups, it is a ketimine. The term "azomethine" is synonymous with secondary aldimine, specifically referring to compounds of the form R–CH=NR′ where R′ ≠ H.

Schiff bases can be synthesized from an aliphatic or aromatic amine and a carbonyl compound by nucleophilic addition forming a hemiaminal, followed by a dehydration to generate an imine. Schiff bases as a class were named after the German chemist Hugo Schiff, who first described them in 1864. These molecules are characterized by a specific chemical signature: a carbon–nitrogen double bond, which makes them highly versatile building blocks in chemical synthesis and biological processes.

Schiff bases are systematically named using the IUPAC suffix "-imine" to denote the C=N functional group, with locants specifying the position of the nitrogen when necessary. Common names for Schiff bases include "anils," which specifically refer to those derived from aromatic amines such as aniline, and "azomethines," a synonym often applied more broadly to secondary aldimines.

Aldimines do not have a single CAS number, botanical source, or standard supplement preparation because they represent an entire functional group class. Individual biologically active or pharmaceutically relevant aldimines are each discrete molecules with their own identities and properties.

Natural Sources and Endogenous Occurrence

Aldimines are not concentrated in specific botanical sources in the way that vitamins, alkaloids, or flavonoids are. Rather, aldimine linkages form naturally and transiently within living organisms as essential intermediates in a variety of well-characterized enzymatic and non-enzymatic biochemical processes. Several of the most physiologically important are described below.

Pyridoxal Phosphate (Vitamin B6) — The Internal and External Aldimine

Pyridoxal 5′-phosphate (PLP) is one of the active forms of vitamin B6, which is produced by pyridoxal kinase-mediated reactions. PLP-dependent enzymes catalyze a wide variety of reaction types and usually have a conserved lysine residue in the active site for PLP binding. The ε-amino group of the lysine residue and the aldehyde group of PLP form a Schiff-base structure. Because this Schiff-base structure is linked through a protein-associated lysine residue, it is commonly referred to as the internal aldimine.

After substrate (amino acid or amine) binding, the internal aldimine breaks up and a new Schiff base structure is formed between the amino group of the substrate and the aldehyde group of PLP via a gem-diamine intermediate; this new linkage is called the external aldimine. Once the amino substrate interacts with the active site, this new Schiff base generated is commonly referred to as the external aldimine. After this step, the mechanistic pathway for each PLP-catalyzed reaction diverges.

PLP acts as a coenzyme in all transamination reactions, and in certain decarboxylation, deamination, and racemization reactions of amino acids. The International Union of Biochemistry and Molecular Biology has catalogued more than 140 PLP-dependent activities, corresponding to approximately 4% of all classified activities. The versatility of PLP arises from its ability to covalently bind the substrate, and then to act as an electrophilic catalyst, thereby stabilizing different types of carbanionic reaction intermediates.

The various reactions of pyridoxal phosphate in amino acid metabolism all depend on the same chemical principle: the ability to stabilize amino acid carbanions and hence to weaken bonds around the α-carbon of the substrate. This is achieved by the reaction of the α-amino group with the carbonyl group of the coenzyme to form a Schiff base (aldimine).

The ring nitrogen of pyridoxal phosphate exerts a strong electron-withdrawing effect on the aldimine, and this leads to weakening of all three bonds around the α-carbon of the substrate. The first reaction between the substrate and the coenzyme is transfer of the aldimine linkage from the ε-amino group of the active-site lysine to the α-amino group of the substrate.

Enzymes that depend on vitamin B6 — in particular on its metabolically active form, pyridoxal 5′-phosphate — are of great relevance to biology and medicine, as they catalyze a wide variety of biochemical reactions mainly involving amino acid substrates. Although PLP-dependent enzymes belong to a small number of independent evolutionary lineages, they encompass more than 160 distinct catalytic functions, thus representing a striking example of divergent evolution.

Rhodopsin and the Visual System

The chromophore retinal is bound to opsin by an aldimine linkage (Schiff base). The covalent linkage is formed between the terminal aldehyde group of retinal and the side-chain amino group of a lysine amino acid residue of the protein. Some Schiff bases are known to play an important role in physiological chemistry. For example, rhodopsin, the pigment of the retina, is known to be essential in vision processing. It occurs biochemically in the reaction of the formyl group of cis-retinal with an amine group of the apoprotein opsin, making rhodopsin an aldimine-type Schiff base.

These model Schiff bases derived from retinal are pH indicators: in alkaline solution they have an absorption maximum around 365 nm, while at lower pH the aldimine linkage is protonated and the maximum shifts to approximately 445 nm. This effect of protonation has led to the suggestion that the aldimine linkage is protonated in rhodopsin, and laser-Raman spectroscopic studies of the native binding site support this notion.

Aldimines in Glycation Chemistry (Advanced Glycation End Products)

An important naturally occurring context for aldimine chemistry is the non-enzymatic glycation of proteins. The initial event in protein glycation is the reaction of a reducing sugar such as glucose with the N-terminus of a protein or the ε-amino group of a lysine to form an aldimine, or Schiff base. The Schiff base can hydrolyze back to its reactants or undergo an Amadori rearrangement to form a more stable N-(1-deoxy-1-fructosyl)lysine, known as the Amadori product.

Condensation of the carbonyl group and the amine group is a reversible reaction yielding the so-called Schiff base (aldimine). In the Maillard pathway, it undergoes Amadori rearrangement, giving a stable Amadori product. The Schiff base displays equilibria between a minor open-chain aldimine and a more stable glycosylamine ring. This aldimine is highly unstable and, thus, it rapidly undergoes an Amadori rearrangement to form a stable ketoamine, known as an Amadori product.

Advanced glycation end products (AGEs) are modifications of proteins or lipids that become nonenzymatically glycated and oxidized after contact with aldose sugars; early glycation and oxidation processes result in the formation of Schiff bases and Amadori products. Glycated Maillard products have a direct association with the pathophysiology of some metabolic diseases, such as diabetes mellitus type 2, acute renal failure, Alzheimer's disease, dental health, allergies, and polycystic ovary syndrome.

Historical and Traditional Use

There is no documented history of "aldimine" as a named ingredient in any traditional medical system — Ayurveda, Traditional Chinese Medicine, Greco-Roman medicine, Western herbalism, or any other recorded pharmacopeia. No WHO monograph, ESCOP monograph, German Commission E monograph, or equivalent official herbal compendium refers to aldimine as a plant-derived ingredient with established traditional use.

The concept of the Schiff base, and by extension the aldimine subclass, was first formally described by the German chemist Hugo Schiff in 1864 as a result of laboratory synthesis. Schiff bases, which were first obtained by the German chemist H. Schiff in 1864, are used in the paint industry, polymer technology, pharmaceutical industry, medicine, agriculture, preparation of rocket fuel, and explanation of biological events, and in many other areas due to the groups in their structures. The identification of internal aldimine linkages in biological molecules such as PLP-dependent enzymes and rhodopsin is entirely a product of 20th-century biochemistry, not traditional medical knowledge.

Claims appearing on certain supplement retail websites that aldimine-containing preparations were historically combined with herbs such as milk thistle, dandelion root, turmeric, or ginger in Ayurvedic or Traditional Chinese Medicine — or that aldimines were specifically valued in traditional medicine — cannot be traced to any authoritative primary or secondary source and should be regarded as unverifiable.

Key Chemical and Biochemical Mechanisms

Schiff Base Formation Mechanism

Schiff bases are usually synthesized from the condensation of primary amines with active carbonyl groups by nucleophilic addition forming a hemiaminal (carbinolamine), followed by dehydration to generate an imine (ketimine, aldimine, hydrazone, or azomethine). The C=N double bond itself is a region of high chemical interest because the nitrogen atom is slightly more electronegative than the carbon atom, making these bonds electrophilic at carbon and important for enzymatic catalysis.

Metal Chelation

Schiff bases are selective toward metal ions and form complexes by transferring electrons from the active ends they contain to the metal. Schiff bases are known as good nitrogen donor ligands (–CH=N–). During the formation of coordination compounds, one or more electron pairs are donated to the metal ion by these ligands. Schiff bases can form highly stable 4-, 5-, and 6-membered ring complexes if they donate more than one electron pair. This chelating capacity is frequently exploited in medicinal chemistry, as it can enhance the bioactivity of aldimine-based pharmaceutical candidates.

Role as Electron Sink in Enzymatic Catalysis

PLP is required for over 100 different reactions in human metabolism, primarily in the various amino acid biosynthetic and degradation pathways. The essential function of PLP is to act as an "electron sink," stabilizing a negative formal charge that develops on key reaction intermediates. This mechanism, mediated through the aldimine bond between PLP and substrate amino acids, is foundational to multiple biosynthetic pathways, including the production of neurotransmitters (via amino acid decarboxylation), heme biosynthesis, and one-carbon metabolism.

Tautomerism: Aldimine–Ketimine Equilibria

Two types of tautomerization have been reported for Schiff base compounds: enol imine–keto enamine and aldimine–ketimine. These tautomeric forms have found relevance in the coordination of various metals, development of organic frameworks, molecular switching, medicinal chemistry, and chemosensors. The aldimine–ketimine tautomerization, although it has been observed in solution for decades, has eluded attempts to structurally characterize either form as a rearrangement of the other until recently.

Pharmacological Research on Aldimine-Type Compounds

A substantial body of in vitro and preclinical (cell culture, animal model) research has explored synthetic aldimine-type Schiff base compounds for potential pharmacological applications. It is critical to note that the vast majority of this research examines purpose-designed synthetic molecules — not naturally occurring food or supplement ingredients — and that human clinical trials specifically targeting aldimine-type Schiff bases as dietary supplements do not exist in the published peer-reviewed literature. The following represents the current state of preclinical and early-stage pharmaceutical research.

Antimicrobial Activity

A short review compiled examples of the most promising antimalarial, antibacterial, antifungal, and antiviral Schiff bases and provided an overview of synthetic methodologies used for their preparation. Schiff bases have a significant role in medical and drug discovery because of their anti-inflammatory, analgesic, antibacterial, anticonvulsant, antitubercular, anticancer, antioxidant, anthelmintic, and cardiovascular activities.

The existence of functional groups that may interact with biological molecules through hydrogen bonds, electrostatic interactions, and covalent bonds is thought to be the cause of Schiff bases' biological activity. The presence of a conjugated system in Schiff bases also contributes to their biological activity by enabling electron transfer and free radical scavenging.

In a 2019 study, Hassan et al. examined the antimicrobial potential of 5-aminopyrazole-derived compounds. These compounds demonstrated remarkable activity against multidrug-resistant bacteria. One Schiff base showed very good activity against Staphylococcus aureus (MIC: 15.62 μg/mL). Further enzymatic assay aided by molecular docking study demonstrated that this compound is a potent inhibitor of S. aureus DNA gyrase and dihydrofolate reductase kinases, making it a valuable candidate for new potent antimicrobial agent discovery.

All of this evidence is preclinical and in vitro. No human clinical trials of aldimine-type Schiff bases as antimicrobial supplements have been conducted or reported.

Anticancer / Antiproliferative Activity

Researchers have focused attention on synthetic simple Schiff bases of aldimine- and ketimine-types revealing anticancer activities in vitro, examining structural variations whose effects on antiproliferative activity in sets of designed molecules have been described in the scientific literature.

One study was designed to evaluate novel aldimine-type Schiff bases bearing 3,4,5-trimethoxyphenyl and 1,2,4-triazole-3-thione/thiol as potential tubulin polymerization inhibitors. Molecular docking results showed that two compounds were well fitted in the colchicine binding site of tubulin with binding energies of −8.68 and −8.40 kcal/mol, respectively, in comparison to the reference ligand (−8.20 kcal/mol). Molecular simulations were also performed on five other targets including Hsp90, VEGFR2, and dihydrofolate reductase from human and microbial sources.

Other research investigated the in vitro antineoplastic activities of novel aldimine-type Schiff bases synthesized by refluxing stoichiometric ratios of amino-containing heterocyclic precursors with aromatic aldehydes. These aldimines were designed to contain the benzenesulfonamide moiety, which is associated with a number of important biological activities.

This entire body of evidence is in vitro (cell-based) and/or computational (molecular docking). None of these synthetic aldimine compounds have advanced to human clinical trials as dietary supplements.

Anti-inflammatory Activity

Schiff bases derived from salicylaldehyde and 2-substituted aniline and their metal chelates with Cu(II), Ni(II), and Co(II) ions were synthesized and screened for anti-inflammatory and antiulcer activity. The compound salicylidene-anthranilic acid was found to possess both anti-inflammatory and antiulcer activity. The copper complexes showed increased antiulcer activity, with the compound possibly acting by influencing prostaglandin biosynthesis. This research is from animal model and early mechanistic studies; no human supplementation trials have followed.

Antioxidant Activity

The presence of a conjugated system in Schiff bases contributes to their biological activity by enabling electron transfer and free radical scavenging. The role of Schiff bases in the in vivo nonenzymatic glycation of macromolecules is also of interest. These reactions take place between a reducing sugar and a macromolecule — DNA, lipid, or protein — and generate advanced glycation end products (AGEs) through a Schiff base intermediary. It is possible that the antioxidant activity described for some Schiff bases is related to the prevention of the protein glycation process, but this connection has not been definitively established.

In one study, 12 Schiff base derivatives of 4-aminoantipyrine were synthesized and their in vitro antimicrobial, antioxidant, and cytotoxicity properties were analyzed. Results identified two potential Schiff bases: one effective against E. faecalis and another with antioxidant activity, both with reasonable ADME scores, providing a scaffold for developing more effective compounds.

Anti-Alzheimer's / Neuroprotective Activity (Preclinical)

Some of the most prominent examples of pharmacologically relevant Schiff bases studied in the context of neurodegeneration include patented inhibitors specific for β-secretase, an enzyme present in aberrantly high levels in Alzheimer's patients; Schiff base copper complexes that target and inhibit reversibly caspase enzymes involved in apoptosis; and Schiff bases of thiazoles specific for urease, an enzyme present in bacteria, fungi, and plants. Significant antidiabetic and anti-Alzheimer activities of Schiff bases and their metal complexes have been defined by biomedical evaluation. All such evidence remains preclinical.

Body Systems Associated with Aldimine Chemistry

Amino Acid Metabolism and Nitrogen Homeostasis

The internal aldimine formed between PLP and the active-site lysine of aminotransferase enzymes is central to amino acid catabolism and biosynthesis. Pyridoxal phosphate (PLP), the active form of vitamin B6, forms a Schiff base with the amino group of amino acids during transamination reactions catalyzed by aminotransferases. This internal aldimine linkage facilitates the transfer of amino groups between amino acids and α-keto acids through a ping-pong mechanism involving proton abstraction and transfer. The resulting ketimine intermediate is then hydrolyzed to release pyridoxamine phosphate (PMP) and the corresponding keto acid, regenerating PLP for subsequent cycles.

Visual System

In the visual system, Schiff bases are essential for phototransduction in rhodopsin, the light-sensitive protein in rod cells of the retina. Rhodopsin is the light receptor in rod photoreceptor cells of the retina that initiates scotopic (low-light) vision. In the dark, rhodopsin is bound to the chromophore 11-cis retinal, which locks the receptor in an inactive state. The aldimine bond between retinal and opsin's lysine residue is the structural basis for light detection and subsequent phototransduction cascades.

Carbohydrate Metabolism and Glycation

Aldimine-type Schiff bases of pyridoxal phosphate coenzyme, being formed in the reaction of a formyl group of pyridoxal phosphate with an amine group of a lysine residue in the active site of a number of specific enzymes, are reported to play a pivotal role in the metabolic pathways of biologically important amino acids. A ketimine-type Schiff base of dihydroxyacetone phosphate, formed in the reaction of the carbonyl group of dihydroxyacetone phosphate with an amino group of a lysine in the active site of aldolase, is found to be involved in carbohydrate metabolism.

In the context of AGE formation, glucose attaches to a free amino acid (mainly lysine and arginine) of a protein, lipid, or DNA in a non-enzymatic way to form a Schiff base. A Schiff base is a compound that has a carbon-to-nitrogen double bond where the nitrogen is not connected to hydrogen. The initiation of this first step depends on glucose concentration and takes place within hours. If the concentration of glucose decreases, this reaction is reversible.

Immune and Inflammatory Systems

Human serine hydroxymethyltransferase 2 (SHMT2) regulates one-carbon transfer reactions required for amino acid and nucleotide metabolism, and exists in dimeric and tetrameric forms. The dimeric SHMT2 variant is a potent inhibitor of the BRISC deubiquitylase enzyme complex, which regulates immune-based cell signaling. Recent studies show that SHMT2 tetramerization is induced by PLP, preventing interaction with the BRISC deubiquitylase complex, potentially linking vitamin B6 levels and metabolism to inflammation. This illustrates that aldimine-forming chemistry of PLP has downstream effects on inflammation-related signaling, though this is a mechanistic observation, not a basis for supplementing with "aldimine" per se.

Dosage Forms and Reported Dosages

There are no established dosage forms or clinical dosages for "aldimine" as a supplement ingredient. No peer-reviewed clinical trials, pharmacopeial monographs, or government health body guidelines specify dosages for administering aldimine as a supplement to humans.

Research on aldimine-type compounds occurs almost entirely at the laboratory bench (in vitro, with cell lines, or in animal models), and synthetic aldimine compounds studied pharmacologically are investigational molecules, not sold or regulated as supplements. Concentration-response data in these preclinical studies (e.g., IC₅₀ values, MIC values in μg/mL) are specific to each individual synthetic molecule tested and cannot be generalized to a supplement concept of "aldimine."

The nutritional context closest to aldimine supplementation involves vitamin B6 (pyridoxal/pyridoxal phosphate), in which PLP-dependent aldimine chemistry is the mechanism of action. The NIH Office of Dietary Supplements and other authoritative bodies have established recommended dietary allowances (RDAs) and tolerable upper intake levels (ULs) for vitamin B6, but these apply to the vitamin itself — not to aldimines as a substance category.

Safety Considerations

Because "aldimine" does not designate a specific supplement ingredient, there is no safety dossier, NOAEL, GRAS determination, or adverse event profile specifically for "aldimine supplements" in the scientific or regulatory literature. The following considerations apply to the biochemical and pharmacological contexts of aldimine chemistry:

Endogenous Aldimine Linkages

Internal aldimine bonds in PLP-dependent enzymes and rhodopsin are normal, essential features of human biochemistry. These are not introduced by supplementation and do not in themselves present safety concerns. Schiff bases are common enzymatic intermediates where an amine, such as the terminal group of a lysine residue, reversibly reacts with an aldehyde or ketone of a cofactor or substrate.

Glycation-Linked Aldimine Chemistry

Within a few hours, reducing sugars containing carbonyl groups react reversibly with the free amino groups of proteins and nucleic acids to form unstable Schiff bases. The driving force of this reaction depends on the glucose concentration. Within a few weeks, Schiff base adducts can undergo spontaneous intramolecular rearrangements that convert them to relatively stable, covalently bound Amadori products. In the context of chronically elevated blood glucose (as in diabetes mellitus), the progressive accumulation of these aldimine-derived AGEs is associated with tissue damage and organ pathology. This is a consequence of glycation chemistry, not an argument for or against any supplement.

Synthetic Aldimine Compounds in Research

Initial studies on synthetic Schiff base compounds are usually limited to laboratory in vitro approaches, and following these initial studies, much research is needed before a drug can reach the clinic. Individual synthetic aldimine-type Schiff bases vary enormously in their structures and toxicological profiles; no generalized safety statement can be made about "aldimines" as a class for human consumption. Some synthetic Schiff bases used in industrial applications (such as polyurethane curing agents) are specifically not intended for human ingestion.

Many drugs possess modified toxicological and pharmacological properties in the form of metal complexes, and Schiff bases are versatile C=N-containing compounds possessing a broad spectrum of biological activity; incorporation of metals in the form of complexes showed some degree of antibacterial, antifungal, antitumor, and anti-inflammatory activity. The metal-chelating properties of aldimine-type Schiff bases that confer pharmacological utility could also, in principle, affect endogenous metal ion homeostasis if administered to humans, but this has not been systematically studied in the context of supplementation.

Current Evidence Strength and Research Gaps

The totality of available evidence on aldimine-type compounds in a health context may be summarized as follows:

• Endogenous biochemistry (established): Aldimine linkages in PLP-dependent enzymes and in rhodopsin are thoroughly characterized at the molecular level and represent essential, well-understood biological chemistry. This is not a basis for supplementation but for understanding vitamin B6 function and visual physiology.
• AGE formation (established, clinically relevant): Aldimine Schiff bases are the first step in non-enzymatic glycation leading to AGE formation, which is established as pathologically significant in diabetes and aging. Managing glycemia, not supplementing with "aldimine," is the clinical intervention here.
• Pharmacological research on synthetic compounds (preclinical only): Synthetic Schiff bases have been reported to exhibit a broad range of biological activities, including antimicrobial, anticancer, anti-inflammatory, and antioxidant properties. However, all robust evidence is in vitro or from animal models. Initial studies are usually limited to laboratory in vitro approaches, and much research is needed before a drug can reach the clinic.
• Dietary supplement use (no evidence base): There are no published randomized controlled trials, cohort studies, case series, or pharmacokinetic studies of "aldimine" administered as a human dietary supplement. No regulatory body has evaluated or approved an "aldimine" supplement claim.

Summary

Aldimine, as a chemical term, denotes an entire class of imine compounds derived from the condensation of aldehydes with primary amines, characterized by the functional group RCH=NR′. These linkages play critical and well-documented roles in human biochemistry: as the "internal" and "external" aldimine bonds that underpin pyridoxal phosphate-dependent enzyme catalysis (affecting amino acid metabolism, neurotransmitter synthesis, and heme production), as the structural bond linking retinal to opsin in visual pigments, and as transient intermediates in the non-enzymatic glycation cascade that ultimately generates AGEs. Synthetic aldimine-type Schiff base compounds have been widely investigated in preclinical pharmacological research for antimicrobial, anticancer, anti-inflammatory, and antioxidant properties, with some promising in vitro and molecular docking results. However, none of these synthetic compounds has been validated in human clinical trials as a supplement. "Aldimine" does not correspond to any recognized supplement monograph, botanical ingredient, isolated nutraceutical, or clinically tested dietary intervention. Claims positioning it as such are not supported by authoritative scientific or regulatory sources.

References

• European Bioinformatics Institute ChEBI: Aldimine (CHEBI:33271)
• Merriam-Webster Dictionary: Aldimine
• Wikipedia: Schiff Base
• ScienceDirect Topics: Schiff Base — Overview
• IntechOpen: Overview of Schiff Bases (in Schiff Base in Organic, Inorganic and Physical Chemistry)
• Biology Insights: What Is a Schiff Base and How Is It Formed?
• PMC / Frontiers in Molecular Biosciences: Current Advances on Structure-Function Relationships of Pyridoxal 5′-Phosphate-Dependent Enzymes
• Wikipedia: Pyridoxal Phosphate
• ScienceDirect Topics: Pyridoxamine Phosphate — Overview
• ScienceDirect Topics: Pyridoxal Phosphate — Overview (Food Science)
• LibreTexts Chemistry: Pyridoxal Phosphate (Vitamin B6)
• PMC: The B6 Database — A Tool for the Description and Classification of Vitamin B6-Dependent Enzymatic Activities
• ScienceDirect Topics: Dehydroretinal — Overview (Rhodopsin aldimine linkage)
• PMC / MDPI Inorganics: Selective Generation of Aldimine and Ketimine Tautomers of Schiff Base Condensates
• PMC / Antibiotics: A Review on the Antimicrobial Activity of Schiff Bases: Data Collection and Recent Studies
• ScienceDirect / Journal of Advanced Research: Schiff Bases — A Short Review of Their Antimicrobial Activities
• PMC / Pharmaceuticals: Pharmacological Activities of Schiff Bases and Their Derivatives with Low and High Molecular Phosphonates
• PMC / Pharmaceuticals: Metal Complexes with Schiff Bases — Data Collection and Recent Studies on Biological Activities
• PMC / Molecules: Characterization of Antimicrobial, Antioxidant, and Leishmanicidal Activities of Schiff Base Derivatives of 4-Aminoantipyrine
• PubMed: Novel Aldimine-Type Schiff Bases of 4-Amino-1,2,4-triazole-3-thione — Docking Study, Synthesis, Biological Evaluation, and Anti-Tubulin Activity
• PubMed: An Insight into Synthetic Schiff Bases Revealing Antiproliferative Activities In Vitro
• ScienceDirect Topics: Schiff Base — Overview (Medicine and Dentistry)
• Springer / Discover Chemistry: Schiff Bases and Their Transition Metal Complexes as Cornerstones in Applied Chemistry
• ScienceDirect: Schiff Bases and Their Possible Therapeutic Applications — A Review
• PMC / Biomolecules: Advanced Glycation End-Products (AGEs) — Formation, Chemistry, Classification, Receptors, and Diseases
• Encyclopedia MDPI: Advanced Glycation End Products (AGEs)
• PMC / Nutrients: Dietary Advanced Glycation End Products and Aging
• AHA Journals / Circulation: Advanced Glycation End Products
• Springer / Biophysical Reviews: An Overview on Glycation — Molecular Mechanisms, Impact on Proteins, Pathogenesis, and Inhibition
• ScienceDirect / Biomedicine & Pharmacotherapy: Novel Advances in Inhibiting Advanced Glycation End Product Formation Using Natural Compounds
• PMC: Schiff Bases and Metal Complexes as Multifunctional Platforms — Bridging Bioinorganic Chemistry, Catalysis, Sensing, and Energy Applications
• PMC / Biomolecules: Advanced Glycation End Products (AGEs) May Be a Striking Link Between Modern Diet and Health
• Grokipedia: Schiff Base